CCL5 and ovarian cancer: Ovarian cancer cells treated with CCL5 showed decreased apoptosis when exposed to cisplatin, which was consistent with the finding that platinum-resistant patient samples expressed elevated CCL5 levels compared to platinum-sensitive samples.